Supergut cites a company-sponsored double-blind RCT showing its resistant starch blend improved postprandial blood sugar in people with type 2 diabetes (results published on the company website
At Lite Medical in Burnsville, MN, we are dedicated to providing personalized, patient-centered care to help you achieve your health goals
Lowest effective dose tailored to you Fewer side effects minimal nausea, fatigue Better protein intake & muscle preservation Dose adjusted based on labs & response Hormone & root-cause investigation Built-in exit strategy from medication Sustainable, long-term results Fixed escalation regardless of response More nausea, vomiting, fatigue Significant muscle loss reported No labs, no individual monitoring Hormones & root causes never addressed No plan to come off medication Weight regain when medication stops How the 12-Week Program Works From your first consultation to your final follow-up, every step is designed to produce lasting results
Only reason for 4 stars is I wish there were more female health products, but they said it's expanding soon
Two GLP-1R agonists have been approved in the United States to treat obesity: semaglutide and LIR, both of which are injected subcutaneously
)
